HHS announced a plan to allow pharmacies to compound six unapproved peptides
HHS will temporarily allow compounding pharmacies to make six unapproved peptides while the FDA reviews them, using enforcement discretion rather than approving the substances. The policy applies in specified circumstances to state-licensed pharmacies, federal facilities and licensed physicians. Pharmacies must verify identity and purity and report adverse events and product-quality issues; FDA scientists raised safety concerns.
More context
HHS announced a plan to temporarily allow compounding pharmacies to make and distribute six peptides that have not been approved by the Food and Drug Administration (FDA), while the agency reviews them. Under enforcement discretion, HHS said it does not intend to take action against state-licensed pharmacies, federal facilities or licensed physicians compounding the substances in specified circumstances. The plan is not FDA approval of the peptides. Pharmacies would have to source ingredients from FDA-registered factories, certify the substances’ identity and purity, report adverse events and notify the agency of product-quality problems, including contamination. FDA staff helped develop these safeguards, though agency scientists had raised major safety concerns and said they would not support a regulation deeming the peptides safe for compounding. The plan follows a July recommendation by an FDA advisory committee to allow compounding.
Was this story useful?
What was the main problem? (optional)
Reporting
- Bloomberg — US to Allow Compounding of Six Peptides in RFK Jr.-Backed Plan - Bloomberg
- iHeart — HHS Temporarily Allows Compounding Pharmacies To Make Six Peptides | Newsradio WOOD 1300 and 106.9 FM
- The Hill — HHS gives compounding pharmacies green light to sell six MAHA-favored peptides
- National Public Radio — Small compounding pharmacies won't be penalized for making peptides : NPR
- CNN — FDA scientists opposed the Trump administration’s move to ease peptides access | CNN
- The Washington Post — RFK Jr. plans to make these 6 unapproved peptides available for temporary sale - The Washington Post
Verifier’s note
Bloomberg, WOOD Radio/iHeart, The Hill, NPR, CNN, and The Washington Post report that the administration is allowing or planning temporary compounding access to six unapproved peptides. Their reports are dated October 28, consistent with the proposed event’s timing.